Literature DB >> 30629338

Factors Associated With Opioid Use in Presurgical Knee, Hip, and Spine Osteoarthritis Patients.

J Denise Power1, Anthony V Perruccio2, Rajiv Gandhi2, Christian Veillette2, J Roderick Davey2, Stephen J Lewis2, Khalid Syed2, Nizar N Mahomed2, Y Raja Rampersaud2.   

Abstract

OBJECTIVE: To evaluate rates of prescription opioid use among patients with presurgical knee, hip, and spine osteoarthritis (OA) and associations between use and sociodemographic and health status characteristics.
METHODS: Participants were patients with presurgical, end-stage OA of the knee (n = 77), hip (n = 459), and spine (n = 168). Data were collected on current use of opioids and other pain medications, as well as measures of sociodemographic and health status variables and depression and pain (0-10 numeric rating scale). Rates of opioid use were calculated by sex, age, and surgical site. Multivariable logistic regression was used to examine associations between opioid use (sometimes/daily versus never) and other study variables.
RESULTS: The mean age of participants was 65.6 years; 55.5% were women, 15% of patients reported "sometimes" using opioids, and 15% reported "daily use." Use of opioids was highest among patients with spine OA (40%) and similar among patients with knee and hip OA (28% and 30%, respectively). Younger women (ages <65 years) reported the greatest use of opioids overall, particularly among patients with spine OA. From multivariable logistic regression, greater likelihood of opioid use was significantly associated with spine OA (versus knee OA), obesity, being a current or former smoker, higher symptomatic joint count, greater depressive symptoms, greater pain, and current use of other prescription pain medication.
CONCLUSION: Nearly one-third of patients with presurgical OA used prescription opioid medication. Given the questionable efficacy of opioids in OA and risk of adverse effects, higher opioid use among younger individuals and those with depressive symptoms is of concern and warrants further investigation.
© 2019, American College of Rheumatology.

Entities:  

Year:  2019        PMID: 30629338     DOI: 10.1002/acr.23831

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  10 in total

1.  High-Risk Prescribing Increases Rates of New Persistent Opioid Use in Total Hip Arthroplasty Patients.

Authors:  Lia D Delaney; Vidhya Gunaseelan; Heidi Rieck; James Michael Dupree; Brian R Hallstrom; Jennifer F Waljee
Journal:  J Arthroplasty       Date:  2020-04-14       Impact factor: 4.757

2.  Association of Patients' Familiarity and Perceptions of Efficacy and Risks With the Use of Opioid Medications in the Management of Osteoarthritis.

Authors:  Ernest R Vina; Cristian Quinones; Leslie R M Hausmann; Said A Ibrahim; C Kent Kwoh
Journal:  J Rheumatol       Date:  2021-01-15       Impact factor: 4.666

3.  Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Andrew Stokes; Sofia Pedro; Ted R Mikuls; Michael George; Bryant R England; Harlan Sayles; Fred Wolfe; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-08-31       Impact factor: 5.178

Review 4.  The Management of Acute Pain for Musculoskeletal Conditions: The Challenges of Opioids and Opportunities for the Future.

Authors:  Lia D Delaney; Daniel J Clauw; Jennifer F Waljee
Journal:  J Bone Joint Surg Am       Date:  2020-05-20       Impact factor: 6.558

5.  Patterns of opioid use (codeine, morphine or meperidine) in the Canadian population over time: analysis of the Longitudinal National Population Health Survey 1994-2011.

Authors:  Mayilee Canizares; J Denise Power; Y Raja Rampersaud; Elizabeth M Badley
Journal:  BMJ Open       Date:  2019-07-24       Impact factor: 2.692

6.  Injectable Amniotic Membrane/Umbilical Cord Particulate for Knee Osteoarthritis: A Prospective, Single-Center Pilot Study.

Authors:  Ramon Castellanos; Sean Tighe
Journal:  Pain Med       Date:  2019-11-01       Impact factor: 3.750

7.  Factors related to the use of opioids as early treatment in patients with knee osteoarthritis.

Authors:  Soo-Kyung Cho; Sun-Young Jung; Seongmi Choi; Seul Gi Im; Hyoungyoung Kim; Woo Seok Choi; Eun Jin Jang; Yoon-Kyoung Sung
Journal:  Arthritis Res Ther       Date:  2019-11-04       Impact factor: 5.156

8.  Sustained acoustic medicine as a non-surgical and non-opioid knee osteoarthritis treatment option: a health economic cost-effectiveness analysis for symptom management.

Authors:  Thomas M Best; Stephanie Petterson; Kevin Plancher
Journal:  J Orthop Surg Res       Date:  2020-10-19       Impact factor: 2.359

9.  The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.

Authors:  Nicole Atkins; Karim Mukhida
Journal:  Can J Pain       Date:  2022-09-01

10.  Opioid prescriptions in patients with osteoarthritis: a population-based cohort study.

Authors:  Jacoline J van den Driest; Dieuwke Schiphof; Marcel de Wilde; Patrick J E Bindels; Johan van der Lei; Sita M A Bierma-Zeinstra
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.